Contact of multiple myeloma cells with mesenchymal stem cells or pre-osteoblasts increased expression of ANGPTL4 in the non-malignant population and enhanced myeloma cell adhesion (81). The gene discussed is ANGPTL4; the disease is plasma cell myeloma.